KEY INSIGHTS
69% have implemented some form of automation
BUT ONLY 9% have fully integrated it across their operations
56% identify high labor, operational costs as the primary obstacles to bringing manufacturing back to their home countries
42% cite regulatory compliance as top barrier to commercializing medical products
31% identified personalized medicine as the most challenging manufacturing trend in 2025
EMERGING TRENDS
Post-COVID supply chain adaptations: Companies are redefining supply chain strategies to mitigate persistent disruptions
AI and predictive analytics: Manufacturers are increasingly leveraging AI to enhance quality assurance, operational efficiency
STRATEGIC OPPORTUNITIES
Regulatory compliance: Best practices to streamline complexity, reduce costs
Automation: Addressing workforce readiness, cost barriers with actionable strategies
Reshoring: Overcoming operational challenges through cost optimization, training programs
The medical and life sciences industry stands at a pivotal crossroads, where challenges such as regulatory hurdles and labor shortages converge with opportunities in automation, AI, and personalized medicine. Learn more in the full report. https://mls.ascentialtech.com/wp-content/uploads/2025/03/0225-IS-Ascential-MLS-State-of-Industry-Report-3.pdf
Explore the June 2025 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Syringe-less injector system for diagnostic imaging obtains fourth FDA clearance
- Hohenstein Medical debuts enhanced medical device testing capabilities
- Arterex unveils unified brand identity
- Dymax demonstrates light-curing material solutions for medical devices
- Able Medical Devices showcases latest sternal closure solutions
- TMTS 2026 explores AI-powered sustainable manufacturing and more
- QT9 QMS platform streamlines quality management, compliance for medical device manufacturers
- Spineology releases patient-specific expandable spinal implant
